One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment

M.C.M. Bunck, A. Mari, A. Corner, B. Eliasson, R.M. Shaginian, R.J. Heine, Y.B. Wu, P. Yan, U. Smith, M.R. Taskinen, H. Yki-Jarvinen, M. Diamant

Research output: Contribution to journalMeeting AbstractOther research output

Original languageUndefined/Unknown
Pages (from-to)S7-S7
Publication statusPublished - 2009

Cite this